These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26303847)

  • 21. Disseminated superficial porokeratosis and pyoderma gangrenosum.
    di Meo N; Fluehler C; Perkan V; Trevisan G
    Dermatol Online J; 2010 Oct; 16(10):15. PubMed ID: 21062609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilic pyoderma gangrenosum with pulmonary and oral lesions preceded by eosinophilic pneumonia: Unrecognized syndromic manifestations?
    Nishioka M; Tani M; Murota H; Katayama I
    Eur J Dermatol; 2011; 21(4):631-2. PubMed ID: 21700533
    [No Abstract]   [Full Text] [Related]  

  • 23. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
    Shenefelt PD
    Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
    Reddick CL; Singh MN; Chalmers RJ
    Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab.
    Swale VJ; Saha M; Kapur N; Hoffbrand AV; Rustin MH
    Clin Exp Dermatol; 2005 Mar; 30(2):134-6. PubMed ID: 15725238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyoderma gangrenosum in a patient with essential thrombocythemia.
    King KW; Murray A
    J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of pyoderma gangrenosum with methotrexate.
    Teitel AD
    Cutis; 1996 May; 57(5):326-8. PubMed ID: 8726713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vulvar pyoderma gangrenosum in a child.
    Garcovich S; Gatto A; Ferrara P; Garcovich A
    Pediatr Dermatol; 2009; 26(5):629-31. PubMed ID: 19840334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case study: diagnosis and treatment of pyoderma gangrenosum.
    Burton J
    Br J Nurs; 2005 Sep 8-21; 14(16):S10-3. PubMed ID: 16215496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of pregnancy in a patient with relapsing polychondritis and pyoderma gangrenosum.
    Tsanadis GD; Chouliara ST; Voulgari PV; Makrydimas GV; Drosos AA
    Clin Rheumatol; 2002 Nov; 21(6):538. PubMed ID: 12447644
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of pyoderma gangrenosum with intravenous immunoglobulin.
    Cummins DL; Anhalt GJ; Monahan T; Meyerle JH
    Br J Dermatol; 2007 Dec; 157(6):1235-9. PubMed ID: 17916196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
    Krauze E; Brzezińska-Wcisło L; Kamińska-Winciorek G; Wygledowska-Kania M; Sygula E
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):589-92. PubMed ID: 16164714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical platelet-derived growth factor accelerates healing of myelodysplastic syndrome-associated pyoderma gangrenosum.
    Braun-Falco M; Stock K; Ring J; Hein R
    Br J Dermatol; 2002 Oct; 147(4):829-31. PubMed ID: 12366451
    [No Abstract]   [Full Text] [Related]  

  • 36. Refractory pyoderma gangrenosum in an infant.
    Etzler C; Cannon S; Hyde P
    Pediatr Dermatol; 2015; 32(1):156-7. PubMed ID: 24894462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A four-year old-child with widespread pyoderma gangrenosum resistant to topical treatment.
    Auriemma M; Carbone A; Blasetti A; Tocco AM; Di Giulio C; Tulli A; Amerio P
    Eur J Dermatol; 2010; 20(6):839-40. PubMed ID: 21056941
    [No Abstract]   [Full Text] [Related]  

  • 38. Pyoderma gangrenosum and its treatment.
    Powell RJ; Holbrook MR; Stevens A
    Lancet; 1997 Dec; 350(9093):1720-1. PubMed ID: 9413459
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapy Insight: pyoderma gangrenosum-old disease, new management.
    Campbell S; Cripps S; Jewell DP
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):587-94. PubMed ID: 16327838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukocyte adsorption apheresis for the treatment of pyoderma gangrenosum.
    Watanabe Y; Yamada H
    J Dermatol; 2008 Dec; 35(12):792-4. PubMed ID: 19239562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.